NF-κB/Bcl-2/Caspase 3信号通路与吲哚美辛作用机制的综述与假说:急性胰腺炎胃肠道功能受损的潜在机制研究
Review and Hypothesis on the NF-κB/Bcl-2/Caspase 3 Signaling Pathway and the Mechanism of Action of Indomethacin: Research on the Potential Mechanism of Gastrointestinal Dysfunction in Acute Pancreatitis
DOI: 10.12677/acm.2026.161006, PDF,   
作者: 付 民:承德医学院研究生学院,河北 承德;陈治国*:承德市中心医院急诊科,河北 承德
关键词: 急性胰腺炎NF-κB信号通路Bcl-2/Caspase 3信号通路吲哚美辛Acute Pancreatitis NF-κB Signaling Pathway Bcl-2/Caspase 3 Signaling Pathway Indomethacin
摘要: 急性胰腺炎是一种严重的炎症性疾病,可导致胃肠道功能障碍,增加病死率。NF-κB信号通路在急性胰腺炎的炎症反应中起关键作用,其激活可诱导多种炎症因子和抗凋亡蛋白的表达,加剧炎症并影响细胞存活。Bcl-2/Caspase 3信号通路也与急性胰腺炎的发展密切相关,调节细胞凋亡过程。NF-κB信号通路与Bcl-2/Caspase 3信号通路存在联系,NF-κB的激活可影响Bcl-2家族蛋白的表达,进而调控细胞凋亡。吲哚美辛是一种非甾体类抗炎药,已被发现可降低急性胰腺炎的风险并减轻胰腺损伤,但其具体机制尚不明确。吲哚美辛是否可以抑制NF-κB信号通路的激活还有待探索,未来可进一步研究吲哚美辛在调节NF-κB和Bcl-2/Caspase 3信号通路中的作用,从而缓解急性胰腺炎引起的胃肠道损伤。
Abstract: Acute pancreatitis is a severe inflammatory condition that can lead to gastrointestinal dysfunction and increased mortality. The NF-κB signaling pathway plays a key role in the inflammatory response of acute pancreatitis; its activation induces the expression of various inflammatory cytokines and anti-apoptotic proteins, thereby exacerbating inflammation and affecting cell survival. The Bcl-2/Caspase 3 signaling pathway is also closely associated with the progression of acute pancreatitis, regulating the process of cell apoptosis. There is crosstalk between the NF-κB and Bcl-2/Caspase 3 pathways—activation of NF-κB can influence the expression of Bcl-2 family proteins, thereby modulating apoptosis. Indomethacin, a nonsteroidal anti-inflammatory drug, has been found to reduce the risk of acute pancreatitis and alleviate pancreatic injury, but its precise mechanism remains unclear. Whether indomethacin can suppress the activation of the NF-κB signaling pathway warrants further investigation. Future studies may explore the role of indomethacin in modulating both the NF-κB and Bcl-2/Caspase 3 pathways to mitigate gastrointestinal damage caused by acute pancreatitis.
文章引用:付民, 陈治国. NF-κB/Bcl-2/Caspase 3信号通路与吲哚美辛作用机制的综述与假说:急性胰腺炎胃肠道功能受损的潜在机制研究[J]. 临床医学进展, 2026, 16(1): 42-49. https://doi.org/10.12677/acm.2026.161006

参考文献

[1] Peery, A.F., Crockett, S.D., Murphy, C.C., Lund, J.L., Dellon, E.S., Williams, J.L., et al. (2019) Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018. Gastroenterology, 156, 254-272.e11. [Google Scholar] [CrossRef] [PubMed]
[2] Strum, W.B. and Boland, C.R. (2023) Advances in Acute and Chronic Pancreatitis. World Journal of Gastroenterology, 29, 1194-1201. [Google Scholar] [CrossRef] [PubMed]
[3] Banks, P.A., Bollen, T.L., Dervenis, C., Gooszen, H.G., Johnson, C.D., Sarr, M.G., et al. (2012) Classification of Acute Pancreatitis—2012: Revision of the Atlanta Classification and Definitions by International Consensus. Gut, 62, 102-111. [Google Scholar] [CrossRef] [PubMed]
[4] Xiao, A.Y., Tan, M.L.Y., Wu, L.M., Asrani, V.M., Windsor, J.A., Yadav, D., et al. (2016) Global Incidence and Mortality of Pancreatic Diseases: A Systematic Review, Meta-Analysis, and Meta-Regression of Population-Based Cohort Studies. The Lancet Gastroenterology & Hepatology, 1, 45-55. [Google Scholar] [CrossRef] [PubMed]
[5] 蒋梦可, 陆宗庆, 周伍明, 等. 1990-2019年中国胰腺炎疾病负担分析[J]. 中国循证医学杂志, 2022, 22(8): 869-875.
[6] 金海港, 蒋桔红, 朱仲鑫. 1990-2019年中国胰腺炎疾病负担分析[J]. 肝胆胰外科杂志, 2022, 34(6): 344-348.
[7] Garg, P.K. and Singh, V.P. (2019) Organ Failure Due to Systemic Injury in Acute Pancreatitis. Gastroenterology, 156, 2008-2023. [Google Scholar] [CrossRef] [PubMed]
[8] Zhang, D., Li, Y., Ding, L., Fu, Y., Dong, X. and Li, H. (2018) Prevalence and Outcome of Acute Gastrointestinal Injury in Critically Ill Patients: A Systematic Review and Meta-Analysis. Medicine, 97, e12970. [Google Scholar] [CrossRef] [PubMed]
[9] Fu, W., Shi, N., Wan, Y., Mei, F., Qiu, B., Bao, Y., et al. (2020) Risk Factors of Acute Gastrointestinal Failure in Critically Ill Patients with Traumatic Brain Injury. Journal of Craniofacial Surgery, 31, e176-e179. [Google Scholar] [CrossRef] [PubMed]
[10] Wang, M. and Lei, R. (2016) Organ Dysfunction in the Course of Severe Acute Pancreatitis. Pancreas, 45, e5-e7. [Google Scholar] [CrossRef] [PubMed]
[11] Zhao, H., Jia, L., Yan, Q., Deng, Q. and Wei, B. (2020) Effect of Clostridium Butyricum and Butyrate on Intestinal Barrier Functions: Study of a Rat Model of Severe Acute Pancreatitis with Intra-Abdominal Hypertension. Frontiers in Physiology, 11, Article ID: 561061. [Google Scholar] [CrossRef] [PubMed]
[12] Bhat, A.A., Uppada, S., Achkar, I.W., Hashem, S., Yadav, S.K., Shanmugakonar, M., et al. (2019) Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk. Frontiers in Physiology, 9, Article ID: 1942. [Google Scholar] [CrossRef] [PubMed]
[13] Wang, H., Segaran, R.C., Chan, L.Y., Aladresi, A.A.M., Chinnathambi, A., Alharbi, S.A., et al. (2019) Gamma Radiation-Induced Disruption of Cellular Junctions in HUVECs Is Mediated through Affecting MAPK/NF-κB Inflammatory Pathways. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 1486232. [Google Scholar] [CrossRef] [PubMed]
[14] Yu, S., He, J. and Xie, K. (2023) Zonula Occludens Proteins Signaling in Inflammation and Tumorigenesis. International Journal of Biological Sciences, 19, 3804-3815. [Google Scholar] [CrossRef] [PubMed]
[15] Wang, J., Zhao, H., Lv, K., Zhao, W., Zhang, N., Yang, F., et al. (2021) Pterostilbene Ameliorates DSS-Induced Intestinal Epithelial Barrier Loss in Mice via Suppression of the NF-κB-Mediated MLCK-MLC Signaling Pathway. Journal of Agricultural and Food Chemistry, 69, 3871-3878. [Google Scholar] [CrossRef] [PubMed]
[16] Beeman, N., Webb, P.G. and Baumgartner, H.K. (2012) Occludin Is Required for Apoptosis When Claudin-Claudin Interactions Are Disrupted. Cell Death & Disease, 3, e273-e273. [Google Scholar] [CrossRef] [PubMed]
[17] Cianci, R., Spada, C., Perri, V., et al. (2008) Active Thymopoiesis in Idiopathic Chronic Pancreatitis. European Review for Medical and Pharmacological Sciences, 12, 41-46.
[18] Luo, M., Jin, T., Fang, Y., Chen, F., Zhu, L., Bai, J., et al. (2025) Signaling Pathways Involved in Acute Pancreatitis. Journal of Inflammation Research, 18, 2287-2303. [Google Scholar] [CrossRef] [PubMed]
[19] Mayerle, J., Sendler, M., Hegyi, E., Beyer, G., Lerch, M.M. and Sahin-Tóth, M. (2019) Genetics, Cell Biology, and Pathophysiology of Pancreatitis. Gastroenterology, 156, 1951-1968.e1. [Google Scholar] [CrossRef] [PubMed]
[20] Mao, H., Zhao, X. and Sun, S. (2025) NF-κB in Inflammation and Cancer. Cellular & Molecular Immunology, 22, 811-839. [Google Scholar] [CrossRef] [PubMed]
[21] Taniguchi, K. and Karin, M. (2018) NF-κB, Inflammation, Immunity and Cancer: Coming of Age. Nature Reviews Immunology, 18, 309-324. [Google Scholar] [CrossRef] [PubMed]
[22] Długosz JW, Andrzejewska A, Nowak K, et al. (2005) The Cumulative Effect of Nuclear Factor-kappaB (NF-kappaB) in-Hibition and Endothelins in Early Cerulein-Induced Acute Pancreatitis in Rats. Roczniki Akademii Medycznej w Bialymstoku, 50, 230-236.
[23] Karin, M. (2006) Nuclear Factor-κB in Cancer Development and Progression. Nature, 441, 431-436. [Google Scholar] [CrossRef] [PubMed]
[24] Ruland, J. (2011) Return to Homeostasis: Downregulation of NF-κB Responses. Nature Immunology, 12, 709-714. [Google Scholar] [CrossRef] [PubMed]
[25] Luo, J.L., Kamata, H. and Karin, M. (2005) IKK/NF-kappaB Signaling: Balancing Life and Death—A New Approach to Cancer Therapy. Journal of Clinical Investigation, 115, 2625-2632. [Google Scholar] [CrossRef] [PubMed]
[26] Virlos, I., Mazzon, E., Serraino, I., Genovese, T., Di Paola, R., Thiemerman, C., et al. (2004) Calpain I Inhibitor Ameliorates the Indices of Disease Severity in a Murine Model of Cerulein-Induced Acute Pancreatitis. Intensive Care Medicine, 30, 1645-1651. [Google Scholar] [CrossRef] [PubMed]
[27] Jakkampudi, A., Jangala, R., Reddy, B.R., Mitnala, S., Reddy, D.N. and Talukdar, R. (2016) NF-κB in Acute Pancreatitis: Mechanisms and Therapeutic Potential. Pancreatology, 16, 477-488. [Google Scholar] [CrossRef] [PubMed]
[28] Carneiro, B.A. and El-Deiry, W.S. (2020) Targeting Apoptosis in Cancer Therapy. Nature Reviews Clinical Oncology, 17, 395-417. [Google Scholar] [CrossRef] [PubMed]
[29] Luna‐Vargas, M.P.A. and Chipuk, J.E. (2016) The Deadly Landscape of Pro‐Apoptotic Bcl‐2 Proteins in the Outer Mitochondrial Membrane. The FEBS Journal, 283, 2676-2689. [Google Scholar] [CrossRef] [PubMed]
[30] Park, H., Broman, K. and Jonas, E. (2021) Oxidative Stress Battles Neuronal Bcl-Xl in a Fight to the Death. Neural Regeneration Research, 16, 12. [Google Scholar] [CrossRef] [PubMed]
[31] Jeng, P.S., Inoue-Yamauchi, A., Hsieh, J.J. and Cheng, E.H. (2018) BH3-Dependent and Independent Activation of BAX and BAK in Mitochondrial Apoptosis. Current Opinion in Physiology, 3, 71-81. [Google Scholar] [CrossRef] [PubMed]
[32] Zhang, Z., Guo, M., Liu, Y., Liu, P., Cao, X., Xu, Y., et al. (2020) RNPS1 Inhibition Aggravates Ischemic Brain Injury and Promotes Neuronal Death. Biochemical and Biophysical Research Communications, 523, 39-45. [Google Scholar] [CrossRef] [PubMed]
[33] Hauseman, Z.J., Harvey, E.P., Newman, C.E., Wales, T.E., Bucci, J.C., Mintseris, J., et al. (2020) Homogeneous Oligomers of Pro-Apoptotic BAX Reveal Structural Determinants of Mitochondrial Membrane Permeabilization. Molecular Cell, 79, 68-83.e7. [Google Scholar] [CrossRef] [PubMed]
[34] Zhang, H., Holzgreve, W. and De Geyter, C. (2000) Evolutionarily Conserved Bok Proteins in the Bcl‐2 Family. FEBS Letters, 480, 311-313. [Google Scholar] [CrossRef] [PubMed]
[35] Mustafa, M., Ahmad, R., Tantry, I.Q., Ahmad, W., Siddiqui, S., Alam, M., et al. (2024) Apoptosis: A Comprehensive Overview of Signaling Pathways, Morphological Changes, and Physiological Significance and Therapeutic Implications. Cells, 13, Article 1838. [Google Scholar] [CrossRef] [PubMed]
[36] Sung, K., Odinokova, I.V., Mareninova, O.A., Rakonczay Jr, Z., Hegyi, P., Pandol, S.J., et al. (2009) Prosurvival Bcl-2 Proteins Stabilize Pancreatic Mitochondria and Protect against Necrosis in Experimental Pancreatitis. Experimental Cell Research, 315, 1975-1989. [Google Scholar] [CrossRef] [PubMed]
[37] Litewka, J.J., Szopa, M.D., Fryt, K., Jakubowska, M.A., Jankowska, U., Skupien-Rabian, B., et al. (2025) Repurposing BCL2 Inhibitors: Venetoclax Protects against Acinar Cell Necrosis in Acute Pancreatitis by Promoting Apoptosis. Cell Death & Disease, 16, Article No. 566. [Google Scholar] [CrossRef] [PubMed]
[38] Thus, Y.J., Eldering, E., Kater, A.P. and Spaargaren, M. (2022) Tipping the Balance: Toward Rational Combination Therapies to Overcome Venetoclax Resistance in Mantle Cell Lymphoma. Leukemia, 36, 2165-2176. [Google Scholar] [CrossRef] [PubMed]
[39] Beg, A.A. and Baltimore, D. (1996) An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death. Science, 274, 782-784. [Google Scholar] [CrossRef] [PubMed]
[40] Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R. and Verma, I.M. (1996) Suppression of TNF-α-Induced Apoptosis by NF-κB. Science, 274, 787-789. [Google Scholar] [CrossRef] [PubMed]
[41] Van Quickelberghe, E., De Sutter, D., van Loo, G., Eyckerman, S. and Gevaert, K. (2018) A Protein-Protein Interaction Map of the TNF-Induced NF-κB Signal Transduction Pathway. Scientific Data, 5, Article No. 180289. [Google Scholar] [CrossRef] [PubMed]
[42] Arfin, S., Jha, N.K., Jha, S.K., Kesari, K.K., Ruokolainen, J., Roychoudhury, S., et al. (2021) Oxidative Stress in Cancer Cell Metabolism. Antioxidants, 10, Article 642. [Google Scholar] [CrossRef] [PubMed]
[43] Campbell, M.T., Dagher, P., Hile, K.L., Zhang, H., Meldrum, D.R., Rink, R.C., et al. (2008) Tumor Necrosis Factor-α Induces Intrinsic Apoptotic Signaling during Renal Obstruction through Truncated Bid Activation. Journal of Urology, 180, 2694-2700. [Google Scholar] [CrossRef] [PubMed]
[44] Ge, P., Luo, Y., Okoye, C.S., Chen, H., Liu, J., Zhang, G., et al. (2020) Intestinal Barrier Damage, Systemic Inflammatory Response Syndrome, and Acute Lung Injury: A Troublesome Trio for Acute Pancreatitis. Biomedicine & Pharmacotherapy, 132, Article 110770. [Google Scholar] [CrossRef] [PubMed]
[45] Liu, Y., Chen, L., Wang, L. and Xiong, Y. (2021) Effects of Intestinal Lymphatic Ligation on Intestinal Immunity in Rats with Severe Acute Pancreatitis. FEBS Open Bio, 11, 1109-1121. [Google Scholar] [CrossRef] [PubMed]
[46] Su, S., Liang, T., Zhou, X., He, K., Li, B. and Xia, X. (2019) Qingyi Decoction Attenuates Severe Acute Pancreatitis in Rats via Inhibition of Inflammation and Protection of the Intestinal Barrier. Journal of International Medical Research, 47, 2215-2227. [Google Scholar] [CrossRef] [PubMed]
[47] Bai, J., Bai, J. and Yang, M. (2021) Interleukin-22 Attenuates Acute Pancreatitis-Associated Intestinal Mucosa Injury in Mice via STAT3 Activation. Gut and Liver, 15, 771-781. [Google Scholar] [CrossRef] [PubMed]
[48] Zhou, Q., Xiang, H., Liu, H., Qi, B., Shi, X., Guo, W., et al. (2021) Emodin Alleviates Intestinal Barrier Dysfunction by Inhibiting Apoptosis and Regulating the Immune Response in Severe Acute Pancreatitis. Pancreas, 50, 1202-1211. [Google Scholar] [CrossRef] [PubMed]
[49] Elmunzer, B.J., Waljee, A.K., Elta, G.H., Taylor, J.R., Fehmi, S.M.A. and Higgins, P.D.R. (2008) A Meta-Analysis of Rectal NSAIDs in the Prevention of Post-ERCP Pancreatitis. Gut, 57, 1262-1267. [Google Scholar] [CrossRef] [PubMed]
[50] Elmunzer, B.J., Scheiman, J.M., Lehman, G.A., Chak, A., Mosler, P., Higgins, P.D.R., et al. (2012) A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis. New England Journal of Medicine, 366, 1414-1422. [Google Scholar] [CrossRef] [PubMed]
[51] Lu, G., Pan, Y., Kayoumu, A., Zhang, L., Yin, T., Tong, Z., et al. (2017) Indomethacin Inhabits the NLRP3 Inflammasome Pathway and Protects Severe Acute Pancreatitis in Mice. Biochemical and Biophysical Research Communications, 493, 827-832. [Google Scholar] [CrossRef] [PubMed]
[52] Geng, C., Li, X., Li, Y., Song, S. and Wang, C. (2020) Nonsteroidal Anti‐inflammatory Drugs Alleviate Severity of Post‐endoscopic Retrograde Cholangiopancreatography Pancreatitis by Inhibiting Inflammation and Reducing Apoptosis. Journal of Gastroenterology and Hepatology, 35, 896-904. [Google Scholar] [CrossRef] [PubMed]
[53] Takada, Y., Bhardwaj, A., Potdar, P. and Aggarwal, B.B. (2004) Nonsteroidal Anti-Inflammatory Agents Differ in Their Ability to Suppress NF-κB Activation, Inhibition of Expression of Cyclooxygenase-2 and Cyclin D1, and Abrogation of Tumor Cell Proliferation. Oncogene, 23, 9247-9258. [Google Scholar] [CrossRef] [PubMed]